Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse.

García-Mesa Y, Giménez-Llort L, López LC, Venegas C, Cristòfol R, Escames G, Acuña-Castroviejo D, Sanfeliu C.

Neurobiol Aging. 2012 Jun;33(6):1124.e13-29. doi: 10.1016/j.neurobiolaging.2011.11.016. Epub 2011 Dec 16.

PMID:
22177720
[PubMed - indexed for MEDLINE]
2.

Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.

García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.

J Alzheimers Dis. 2011;24(3):421-54. doi: 10.3233/JAD-2011-101635.

PMID:
21297257
[PubMed - indexed for MEDLINE]
3.

Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms.

García-Mesa Y, Pareja-Galeano H, Bonet-Costa V, Revilla S, Gómez-Cabrera MC, Gambini J, Giménez-Llort L, Cristòfol R, Viña J, Sanfeliu C.

Psychoneuroendocrinology. 2014 Jul;45:154-66. doi: 10.1016/j.psyneuen.2014.03.021. Epub 2014 Apr 6.

PMID:
24845186
[PubMed - indexed for MEDLINE]
4.
5.

A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease.

Spuch C, Antequera D, Isabel Fernandez-Bachiller M, Isabel Rodríguez-Franco M, Carro E.

Neurotox Res. 2010 May;17(4):421-31. doi: 10.1007/s12640-009-9121-2. Epub 2009 Sep 23.

PMID:
19774434
[PubMed - indexed for MEDLINE]
6.

Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways.

Giuliani D, Bitto A, Galantucci M, Zaffe D, Ottani A, Irrera N, Neri L, Cavallini GM, Altavilla D, Botticelli AR, Squadrito F, Guarini S.

Neurobiol Aging. 2014 Mar;35(3):537-47. doi: 10.1016/j.neurobiolaging.2013.08.030. Epub 2013 Oct 1.

PMID:
24094579
[PubMed - indexed for MEDLINE]
7.

Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.

Baño Otalora B, Popovic N, Gambini J, Popovic M, Viña J, Bonet-Costa V, Reiter RJ, Camello PJ, Rol MÁ, Madrid JA.

Chronobiol Int. 2012 Aug;29(7):822-34. doi: 10.3109/07420528.2012.699119.

PMID:
22823866
[PubMed - indexed for MEDLINE]
8.

Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain.

Revilla S, Suñol C, García-Mesa Y, Giménez-Llort L, Sanfeliu C, Cristòfol R.

Neuropharmacology. 2014 Jun;81:55-63. doi: 10.1016/j.neuropharm.2014.01.037. Epub 2014 Jan 31.

PMID:
24486380
[PubMed - indexed for MEDLINE]
9.

Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.

Feng Z, Qin C, Chang Y, Zhang JT.

Free Radic Biol Med. 2006 Jan 1;40(1):101-9. Epub 2005 Sep 7.

PMID:
16337883
[PubMed - indexed for MEDLINE]
10.

Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.

Feng Z, Chang Y, Cheng Y, Zhang BL, Qu ZW, Qin C, Zhang JT.

J Pineal Res. 2004 Sep;37(2):129-36.

PMID:
15298672
[PubMed - indexed for MEDLINE]
11.

Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.

Sterniczuk R, Dyck RH, Laferla FM, Antle MC.

Brain Res. 2010 Aug 12;1348:139-48. doi: 10.1016/j.brainres.2010.05.013. Epub 2010 May 31.

PMID:
20471965
[PubMed - indexed for MEDLINE]
12.

Voluntary running and environmental enrichment restores impaired hippocampal neurogenesis in a triple transgenic mouse model of Alzheimer's disease.

Rodríguez JJ, Noristani HN, Olabarria M, Fletcher J, Somerville TD, Yeh CY, Verkhratsky A.

Curr Alzheimer Res. 2011 Nov;8(7):707-17.

PMID:
21453244
[PubMed - indexed for MEDLINE]
13.

Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.

España J, Giménez-Llort L, Valero J, Miñano A, Rábano A, Rodriguez-Alvarez J, LaFerla FM, Saura CA.

Biol Psychiatry. 2010 Mar 15;67(6):513-21. doi: 10.1016/j.biopsych.2009.06.015. Epub 2009 Aug 7.

PMID:
19664757
[PubMed - indexed for MEDLINE]
14.

Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.

Dragicevic N, Copes N, O'Neal-Moffitt G, Jin J, Buzzeo R, Mamcarz M, Tan J, Cao C, Olcese JM, Arendash GW, Bradshaw PC.

J Pineal Res. 2011 Aug;51(1):75-86. doi: 10.1111/j.1600-079X.2011.00864.x. Epub 2011 Mar 1.

PMID:
21355879
[PubMed - indexed for MEDLINE]
15.

Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.

Matsubara E, Bryant-Thomas T, Pacheco Quinto J, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA, Chain DG, Neria E.

J Neurochem. 2003 Jun;85(5):1101-8. Erratum in: J Neurochem. 2003 Sep;86(5):1312.

PMID:
12753069
[PubMed - indexed for MEDLINE]
16.

Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.

Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW.

J Pineal Res. 2009 Aug;47(1):82-96. doi: 10.1111/j.1600-079X.2009.00692.x. Epub 2009 Jun 17.

PMID:
19538338
[PubMed - indexed for MEDLINE]
17.

Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes.

Sterniczuk R, Antle MC, Laferla FM, Dyck RH.

Brain Res. 2010 Aug 12;1348:149-55. doi: 10.1016/j.brainres.2010.06.011. Epub 2010 Jun 15.

PMID:
20558146
[PubMed - indexed for MEDLINE]
18.

Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice.

Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ.

J Neurosci. 2007 Nov 28;27(48):13357-65.

PMID:
18045930
[PubMed - indexed for MEDLINE]
Free Article
19.

High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.

Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.

Neuroscience. 2009 Mar 3;159(1):296-307. doi: 10.1016/j.neuroscience.2008.12.006. Epub 2008 Dec 14.

PMID:
19135506
[PubMed - indexed for MEDLINE]
20.

The neuroprotective role of melatonin against amyloid beta peptide injected mice.

Masilamoni JG, Jesudason EP, Dhandayuthapani S, Ashok BS, Vignesh S, Jebaraj WC, Paul SF, Jayakumar R.

Free Radic Res. 2008 Jul;42(7):661-73. doi: 10.1080/10715760802277388.

PMID:
18654881
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk